Glucagon-like Peptide-1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint Inhibitors.
Chiang CH, Song J, Chi KY, Chang YC, Xanthavanij N, Chang Y, Hsia YP, Chiang CH, Ghamari A, Reynolds KL, Lin S, Xu XH, Neilan TG.
Chiang CH, et al. Among authors: chang y, chang yc.
Eur J Cancer. 2024 Dec 11;216:115170. doi: 10.1016/j.ejca.2024.115170. Online ahead of print.
Eur J Cancer. 2024.
PMID: 39709670